Cost-effectiveness and budget impact analysis of a population-based screening program for colorectal cancer

European Journal of Internal Medicine

Volumn 32, Issue , 2016, Pages 72-78

  Pil, L ^a   Fobelets, M ^b   Putman, K ^b   Trybou, J ^a   Annemans, L ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Cancer screening; Cost effectiveness; Markov model

Indexed keywords

ADULT; AGED; ARTICLE; BELGIUM; BUDGET; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HIDDEN MARKOV MODEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; QUALITY ADJUSTED LIFE YEAR; CHEMISTRY; COLONOSCOPY; COLORECTAL NEOPLASMS; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMIC MODEL; ECONOMICS; FECES; IMMUNOCHEMISTRY; MIDDLE AGED; OCCULT BLOOD;

HEMOGLOBIN;

AGED; BELGIUM; BUDGETS; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; MODELS, ECONOMIC; OCCULT BLOOD; QUALITY-ADJUSTED LIFE YEARS;

EID: 84964907137     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2016.03.031     Document Type: Article

References (37)

1. Stichting Tegen Kanker Distribution of Cancer in Males and Females, Belgium 2015
2. Stichting Tegen Kanker Colorectal Cancer - General Data 2011
3. European commission European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis 2010
4. Council of the European Union Cancer screening in the European Union Report on the Implementation of the Council Recommendation on Cancer Screening 2003
5. U.S.Preventive Services Task Force Screening for Colorectal Cancer 2008
6. J. Faivre, V. Dancourt, C. Lejeune, M.A. Tazi, J. Lamour, D. Gerard, and et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study Gastroenterology 126 2004 1674 1680
7. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, T.W. Balfour, and et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
8. O. Kronborg, C. Fenger, J. Olsen, O.D. Jorgensen, and O. Sondergaard Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
9. M. Zorzi, U. Fedeli, E. Schievano, E. Bovo, S. Guzzinati, S. Baracco, and et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test Gut 64 2015 784 790
10. L. Ventura, P. Mantellini, G. Grazzini, G. Castiglione, C. Buzzoni, T. Rubeca, and et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence Dig Liver Dis 46 2014 82 86
11. L. Sharp, L. Tilson, S. Whyte, A. O'Ceilleachair, C. Walsh, C. Usher, and et al. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy Br J Cancer 106 2012 805 816
12. J.J. Telford, A.R. Levy, J.C. Sambrook, D. Zou, and R.A. Enns The cost-effectiveness of screening for colorectal cancer CMAJ 182 2010 1307 1313
13. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM Classification of Malignant Tumours 7th ed. 2009
14. Stichting kankerregister Prevalence of Colorectal Cancer 2010 2013
15. H. Brenner, L. Altenhofen, C. Stock, and M. Hoffmeister Incidence of colorectal adenomas: birth cohort analysis among 4.3 million participants of screening colonoscopy Cancer Epidemiol Biomarkers Prev 23 2014 1920 1927
16. GLOBOCAN Incidence/Mortality Rates: Cancers by Population 2012
17. Centrum voor Kankeropsporing Annual report screening program 2013 2014
18. S.L. Goede, A.H. van Roon, J.C. Reijerink, A.J. van Vuuren, I. Lansdorp-Vogelaar, J.D. Habbema, and et al. Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening Gut 62 2013 727 734
19. J.A. Wilschut, L. Hol, E. Dekker, J.B. Jansen, M.E. van Leerdam, I. Lansdorp-Vogelaar, and et al. Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening Gastroenterology 141 2011 1648 1655
20. J.T. Kovarova, M. Zavoral, T. Zima, A. Zak, P. Kocna, P. Kohout, and et al. Improvements in colorectal cancer screening programmes - quantitative immunochemical faecal occult blood testing - how to set the cut-off for a particular population Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156 2012 143 150
21. J. Cullen, M.D. Schwartz, W.F. Lawrence, J.V. Selby, and J.S. Mandelblatt Short-term impact of cancer prevention and screening activities on quality of life J Clin Oncol 22 2004 943 952
22. J. Pacolet, A. De Coninck, G. Hedebouw, S. Cabus, and N. Spruytte De medische en niet-medische kosten van kankerpatiënten 2011 HIVA-K.U Leuven
23. L. Tilson, L. Sharp, C. Usher, W. Walsh C. S., A. O'Ceilleachair, C. Stuart, and et al. Cost of care for colorectal cancer in Ireland: a health care payer perspective Eur J Health Econ 13 2012 511 524
24. L. Hakkaart-van Roijen, S. Tan, and C.A.M. Bouwmans Handleiding voor kostenonderzoek: Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg 2010 College voor Zorgverzekeringen
25. Federaal Kenniscentrum voor de gezondheidszorg Belgian Guidelines for Economic Evaluations and Budget Impact Analyses 2nd ed. 2012
26. L. Hol, J.A. Wilschut, B.M. Van, A.J. van Vuuren, V. van d, J.C. Reijerink, and et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 2009 1103 1110
27. C. Hassan, R. Benamouzig, C. Spada, T. Ponchon, A. Zullo, J.C. Saurin, and et al. Cost effectiveness and projected national impact of colorectal cancer screening in France Endoscopy 43 2011 780 793
28. C. Lejeune, V. Dancourt, P. Arveux, C. Bonithon-Kopp, and J. Faivre Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test Int J Technol Assess Health Care 26 2010 40 47
29. D. Heresbach, P. Chauvin, J. Grolier, and J.M. Josselin Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests Eur J Gastroenterol Hepatol 22 2010 1372 1379
30. M. Fobelets, L. Pil, K. Putman, and L. Annemans Cost-Effectiveness and Budget Impact Analysis of a Population-Based Screening Program for Breast Cancer 2016 [in submission]
31. P. Hewitson, P. Glasziou, L. Irwig, B. Towler, and E. Watson Screening for colorectal cancer using the faecal occult blood test, Hemoccult Cochrane Database Syst Rev 2007 CD001216
32. H. Brenner, and S. Tao Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy Eur J Cancer 49 2013 3049 3054
33. L. Guittet, V. Bouvier, N. Mariotte, J.P. Vallee, D. Arsene, S. Boutreux, and et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
34. P. Pickhardt, C. Hassan, A. Laghi, A. Zullo, D.H. Kim, and S. Morini Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions Cancer 109 11 2007 Jun 1 2213 2221
35. C. Hur, D.C. Chung, R.E. Schoen, and G.S. Gazelle The management of small polyps found by virtual colonoscopy: results of a decision analysis Clin Gastroenterol Hepatol 5 2 2007 Feb 237 244
36. C.N. Manser, and P. Bauerfeind Impact of socioeconomic status on incidence, mortality, and survival of colorectal cancer patients: a systematic review Gastrointest Endosc 80 2014 42 60
37. L. Rabeneck, and I. Lansdorp-Vogelaar Assessment of a cancer screening program Best Pract Res Clin Gastroenterol 29 2015 979 985